PHO.OL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 666 min ago

@ NOK53.80

Išleistas: 24 bal. 2024 @ 15:27

Grąža: 1.12%

Ankstesnis signalas: bal. 24 - 14:52

Ankstesnis signalas: Pardavimas

Grąža: -0.37 %

Live Chart Being Loaded With Signals

Commentary (24 bal. 2024 @ 17:25):
Our systems believe the stock currently is undervalued by 0.78% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	31 818.00
Vidutinė apimtis	81 055.00
Rinkos kapitalizacija	1.47B
EPS	NOK0 ( 2024-02-20 )
Kita pelno data	( NOK-0.300 ) 2024-05-15
Last Dividend	NOK2.00 ( 2013-05-23 )
Next Dividend	NOK0 ( N/A )
P/E	-43.87
ATR14	NOK0.900 (1.67%)

Koreliacija (AI algo v.1.1b): Undervalued: 0.78% NOK54.22 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.10 (neutral)

Trumpas: 0.00 (neutral)

Signal:(36) Neutral

Photocure ASA Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AKH.OL	0.929
NAPA.OL	0.913
VOLUE.OL	0.91
ELABS.OL	0.896
NRC.OL	0.895
TRVX.OL	0.881
ENTRA.OL	0.88
EFUEL.OL	0.878
XXL.OL	0.876
AKRBP.OL	0.875

10 Labiausiai neigiamai susiję koreliacijos
NAVA.OL	-0.921
ENDUR.OL	-0.888
NORSE.OL	-0.874
NTEL.OL	-0.871
ASTK.OL	-0.867
BWLPG.OL	-0.866
SNI.OL	-0.864
SMOP.OL	-0.861
AYFIE.OL	-0.86
BORR.OL	-0.842

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Photocure ASA Koreliacija - Valiuta/Žaliavos

0.13
( neutral )

0.07
( neutral )

0.00
( neutral )

0.11
( neutral )

0.36
( neutral )

-0.49
( neutral )

Photocure ASA Finansinės ataskaitos

Annual	2023
Pajamos:	NOK500.66M
Bruto pelnas:	NOK446.83M (89.25 %)
EPS:	NOK0.00990

Q4	2023
Pajamos:	NOK142.55M
Bruto pelnas:	NOK129.22M (90.65 %)
EPS:	NOK0.460

Q3	2023
Pajamos:	NOK107.55M
Bruto pelnas:	NOK100.65M (93.59 %)
EPS:	NOK-0.180

Q2	2023
Pajamos:	NOK144.32M
Bruto pelnas:	NOK137.44M (95.23 %)
EPS:	NOK0.160

Financial Reports:

No articles found.

Photocure ASA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)

Photocure ASA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.81 - No dividend growth expected in the near future

Information

First Dividend	NOK4.00	2009-11-26
Last Dividend	NOK2.00	2013-05-23
Next Dividend	NOK0	N/A
Payout Date	2013-06-11
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	NOK6.00	--
Avg. Dividend % Per Year	0.00%	--
Score	2.43	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.81
Div. Directional Score	7.36	--

Next Divdend (Est)
(2027-03-31)

NOK0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

2.43

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2009	NOK4.00	18.30%
2010	NOK0	0.00%
2011	NOK0	0.00%
2012	NOK0	0.00%
2013	NOK2.00	5.14%
2014	NOK0	0.00%
2015	NOK0	0.00%
2016	NOK0	0.00%
2017	NOK0	0.00%
2018	NOK0	0.00%
2019	NOK0	0.00%
2020	NOK0	0.00%
2021	NOK0	0.00%
2022	NOK0	0.00%
2023	NOK0	0.00%
2024	NOK0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ALNG.OL	Dividend King	2023-11-27	Quarterly	2	6.60%	7.04
OKEA.OL	Dividend Knight	2023-12-01	Quarterly	3	5.65%	6.86
SALM.OL	Dividend Knight	2023-06-09	Annually	17	2.80%	4.97
BWLPG.OL	Dividend Knight	2023-11-17	Quarterly	11	1.68%	4.46
ELK.OL	Dividend Knight	2023-05-02	Annually	6	6.64%	4.31
BWO.OL	Dividend Knight	2023-11-20	Quarterly	14	0.87%	3.96
ATEA.OL	Dividend Knight	2023-11-20	Annually	16	2.97%	3.45
HAFNI.OL	Dividend Knight	2023-11-23	Semi-Annually	5	1.18%	3.31
AKER.OL	Dividend Knight	2023-11-07	Semi-Annually	20	2.99%	3.13
AUSS.OL	Dividend Knight	2023-05-26	Annually	17	3.23%	2.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.000535	1.500	9.99	10.00	[0 - 0.5]
returnOnAssetsTTM	0.000377	1.200	9.99	10.00	[0 - 0.3]
returnOnEquityTTM	0.000572	1.500	-1.105	-1.657	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.80	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.32	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.35	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0276	-1.500	9.54	-10.00	[0 - 0.6]
interestCoverageTTM	1.535	1.000	-0.543	-0.543	[3 - 30]
operatingCashFlowPerShareTTM	1.947	2.00	9.35	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.494	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0.0407	-1.500	9.84	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.933	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.131	1.000	9.39	9.39	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.69	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.704	0.800	8.64	6.91	[0.5 - 2]
Total Score				11.91

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5 485.07	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.000572	2.50	-0.710	-1.657	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.494	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.947	2.00	9.35	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-232.86	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.105	1.000	9.86	0	[0.1 - 0.5]
Total Score				2.81

Photocure ASA

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.